In a molecular analysis of 333 primary prostate cancers, the Cancer Genome Atlas (TCGA) study showed a 19% prevalence of alterations in several DNA repair genes, including BRCA2, BRCA1, ATM, CDK12, FANCD2, and RAD51C [30]. This evidence concerns the gene CDK12 and prostate cancer.